drug protocol number

COMB157G2301

drug sponsor

Novartis

drug study

ofatumumab

drug trial site

King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase